US
US Biosensors Market Industry Trends and Forecast to 2034: Segmented by (Type, Application, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $12.92 Bn.
Canada at 7.9% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$8.54 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $12.21 Bn | — | — |
| 2025 (base) | $12.92 Bn | +$708.4 Mn | — |
| 2026 (forecast) | $13.67 Bn | +$749.5 Mn | +5.8% |
| 2027 (forecast) | $14.47 Bn | +$793.0 Mn | +11.9% |
| 2028 (forecast) | $15.30 Bn | +$839.0 Mn | +18.4% |
| 2029 (forecast) | $16.19 Bn | +$887.7 Mn | +25.3% |
| 2030 (forecast) | $17.13 Bn | +$939.1 Mn | +32.6% |
| 2031 (forecast) | $18.12 Bn | +$993.6 Mn | +40.3% |
| 2032 (forecast) | $19.18 Bn | +$1.05 Bn | +48.4% |
| 2033 (forecast) | $20.29 Bn | +$1.11 Bn | +57% |
| 2034 (forecast) | $21.46 Bn | +$1.18 Bn | +66.1% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$12.92 Bn
China
$2.81 Bn
Canada
$2.48 Bn
Japan
$2.22 Bn
Germany
$1.25 Bn
France
$892.2 Mn
Brazil
$895.0 Mn
Italy
$815.1 Mn
UK
$730.8 Mn
India
$660.7 Mn
Spain
$593.7 Mn
Ecuador
$576.0 Mn
Saudi Arabia
$572.7 Mn
Mexico
$429.4 Mn
Australia
$431.9 Mn
Russia
$370.0 Mn
New Zealand
$366.5 Mn
South Africa
$204.6 Mn
UAE
$180.9 Mn
Egypt
$87.6 Mn
Philippines
$72.0 Mn
Malaysia
$58.1 Mn
Hong Kong
$48.1 Mn
Thailand
$44.6 Mn
Singapore
$43.4 Mn
Kenya
$25.7 Mn
Biosensors are devices that detect biological signals such as glucose, lactate or heart activity and turn them into data.
Key segments of the biosensors market include type (Electrochemical, Optical and Piezoelectric) and application (Medical, Food Testing and Environmental).
Better sensors, longer battery life, smartphone apps and interest in tracking health every day are driving the biosensors market. Doctors are starting to use wearable data in care decisions.
Medical-grade wearables, links to virtual care programs and insurer-funded prevention give the biosensors market strong growth.
Questions about accuracy, data privacy, limited reimbursement and users who stop wearing devices hold back the biosensors market.
The biosensors market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how biosensors products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.
What doctors and scientists are doing in Biosensors right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.
[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
From our blog
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US
US
Digital Health · US
Digital Health · US
Healthcare Services · US
Healthcare Services · US
Digital Health · US
Pharmaceuticals · US